AmeriServ Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AmeriServ Wealth Advisors's AMGN Position: Q2 2022 in Review
AmeriServ Wealth Advisors sold out of Amgen (AMGN) in Q2 2022, closing a stake of 4,822 shares — an estimated $1.17M sold.
AmeriServ Wealth Advisors first reported a position in AMGN in Q2 2015 and held it in 16 quarters. The position peaked at $1.63M in Q3 2018. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- AmeriServ Wealth Advisors reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
- AmeriServ Wealth Advisors sold 4,822 Amgen shares in Q2 2022, an estimated $1.17M.
- AmeriServ Wealth Advisors first reported a position in Amgen in Q2 2015 and held it in 16 quarters.
- AmeriServ Wealth Advisors's Amgen position peaked at $1.63M in Q3 2018.
- 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on AmeriServ Wealth Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.